Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a randomized, double-blind, placebo-controlled,clinical phase I/II treatment trial (Parallel Assignment) evaluating Lacticaseibacillus rhamnosus LCR35 (BGY-1601) in women with acute vaginal infections, bacterial vaginosis (BV), Vulvovaginal candidiasis (VVC) / Vaginal yeast infection, and mixed infections. The treatment is administered with a vaginal tablet called BGY-1601-VT.
To compare the efficacy of BGY-1601-VT, dosing regimen #1 versus placebo and dosing regimen #2 versus placebo, to treat acute vaginal infect…